Virtu KCG Holdings’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.51M Sell
8,640
-17,060
-66% -$2.87M 0.04% 356
2017
Q1
$3.95M Buy
25,700
+7,611
+42% +$1.16M 0.11% 94
2016
Q4
$2.55M Buy
18,089
+16,024
+776% +$2.36M 0.06% 210
2016
Q3
$328K Sell
2,065
-2,805
-58% -$432K 0.01% 1827
2016
Q2
$720K Sell
4,870
-9,360
-66% -$1.38M 0.02% 1019
2016
Q1
$2.02M Buy
+14,230
New +$1.91M 0.06% 270
2015
Q4
Sell
-3,584
Closed -$478K 3934
2015
Q3
$438K Sell
3,584
-3,014
-46% -$393K 0.01% 1669
2015
Q2
$856K Sell
6,598
-594
-8% -$77.4K 0.02% 989
2015
Q1
$966K Sell
7,192
-16,713
-70% -$2.15M 0.02% 807
2014
Q4
$3M Buy
23,905
+4,649
+24% +$565K 0.05% 267
2014
Q3
$2.34M Buy
19,256
+640
+3% +$77.8K 0.05% 381
2014
Q2
$2.2M Sell
18,616
-30,310
-62% -$3.57M 0.03% 483
2014
Q1
$5.88M Buy
48,926
+41,870
+593% +$4.98M 0.07% 214
2013
Q4
$786K Buy
7,056
+998
+16% +$99.2K 0.01% 1462
2013
Q3
$558K Buy
+6,058
New +$548K 0.01% 1873

Other funds holding TMO

Virtu KCG Holdings's TMO Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Thermo Fisher Scientific (TMO) stake by 66% in Q2 2017, selling an estimated $2.87M and leaving 8,640 shares worth $1.51M. The position accounts for 0.04% of the portfolio, ranked #356.

Virtu KCG Holdings first reported a position in TMO in Q3 2013 and has held it in 15 quarters since. The position peaked at $5.88M in Q1 2014. 1,159 funds tracked by Wall St. Rank hold TMO as of Q2 2017.

  • Virtu KCG Holdings held 8,640 shares of Thermo Fisher Scientific worth $1.51M as of Q2 2017.
  • Virtu KCG Holdings sold 17,060 Thermo Fisher Scientific shares in Q2 2017, an estimated $2.87M.
  • Thermo Fisher Scientific made up 0.04% of Virtu KCG Holdings's portfolio in Q2 2017, its #356 holding.
  • Virtu KCG Holdings first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 15 quarters since.
  • Virtu KCG Holdings's Thermo Fisher Scientific position peaked at $5.88M in Q1 2014.
  • 1,159 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.